The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "nASHOST" prospective observational trial

Surgery for Obesity and Related Diseases

Volumn 11, Issue 6, 2015, Pages 1315-1322

  Praveen Raj, P ^a,b   Gomes, Rachel M ^a   Kumar, Saravana ^a   Senthilnathan, Palanisamy ^a   Karthikeyan, Purushothaman ^a   Shankar, Annapoorni ^a   Palanivelu, Chinnusamy ^a  

^a GEM Hospital and Research Centre   (India)

^b GEM HOSPITAL   (India)

Author keywords

Bariatric surgery; Cirrhosis; Metabolic syndrome; Morbid obesity; Nonalcoholic liver disease; Nonalcoholic steatohepatitis

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BARIATRIC SURGERY; BIOCHEMISTRY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INDIAN; INTERVENTION STUDY; LIVER BIOPSY; LIVER FATTY DEGENERATION; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PATHOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLEEVE GASTRECTOMY; STEATOSIS; STOMACH BYPASS; WEIGHT REDUCTION; BIOPSY; BODY MASS; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; GASTRIC BYPASS SURGERY; INDIA; MORBIDITY; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PATHOPHYSIOLOGY; PROCEDURES; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

ADULT; BIOPSY; BODY MASS INDEX; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; INDIA; MALE; MORBIDITY; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84952874235     PISSN: 15507289     EISSN: 18787533     Source Type: Journal    
DOI: 10.1016/j.soard.2015.02.006     Document Type: Article

References (46)

1. A. Duseja, A. Das, R. Das, and et al. The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West Dig Dis Sci 52 9 2007 2368 2374
2. A. Duseja Nonalcoholic fatty liver disease in India - a lot done, yet more required! Indian J Gastroenterol 29 6 2010 217 225
3. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 4 2008 339 350
4. C. Beymer, K.V. Kowdley, A. Larson, P. Edmonson, E.P. Dellinger, and D.R. Flum Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery Arch Surg 138 11 2003 1240 1244
5. H. Boppidi, and S.R. Daram Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome Postgrad Med 120 2 2008 E01 E07
6. C.H. Kim, and Z.M. Younossi Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome Cleve Clin J Med 75 10 2008 721 728
7. H. Tilg, and A. Moschen Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease Minerva Gastroenterol Dietol 56 2 2010 159 167
8. J.M. Clark Weight loss as a treatment for nonalcoholic fatty liver disease J Clin Gastroenterol 40 Suppl 1 2006 S39 S43
9. R.E. Brolin Bariatric surgery and long-term control of morbid obesity JAMA 288 22 2002 2793 2796
10. H. Buchwald, Y. Avidor, E. Braunwald, and et al. Bariatric surgery: a systematic review and meta-analysis JAMA 292 14 2004 1724 1737
11. I. Ranløv, and F. Hardt Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity Digestion 47 4 1990 208 214
12. C.C. Mottin, M. Moretto, A.V. Padoin, and et al. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery Obes Surg 15 6 2005 788 793
13. J.M. Clark, A.R.A. Alkhuraishi, S.F. Solga, P. Alli, A.M. Diehl, and T.H. Magnuson Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease Obes Res 13 7 2005 1180 1186
14. J.B. Dixon, P.S. Bhathal, N.R. Hughes, and P.E. O'Brien Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss Hepatology 39 6 2004 1647 1654
15. S.G. Mattar, L.M. Velcu, M. Rabinovitz, and et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome Ann Surg 242 4 2005 610 620
16. Dixon J.B., Bhathal P.S., O'Brien P.E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 200;16(10):1278-1286.
17. S.R. De Almeida, P.R.S. Rocha, M.D. Sanches, and et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity Obes Surg 16 3 2006 270 278
18. K. Jaskiewicz, S. Raczynska, R. Rzepko, and Z. Sledziński Nonalcoholic fatty liver disease treated by gastroplasty Dig Dis Sci 51 1 2006 21 26
19. C.K. Furuya, CPMS de Oliveira, E.S. de Mello, and et al. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years J Gastroenterol Hepatol 22 4 2007 510 514
20. R.A. Weiner Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease Dig Dis 28 1 2010 274 279
21. NIH conference Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel Ann Intern Med 115 12 1991 956 961
22. R.J. Wong, and A. Ahmed Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations World J Hepatol 6 5 2014 263 273
23. D.E. Kleiner, E.M. Brunt, M. Van Natta, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 6 2005 1313 1321
24. J.P. Ong, H. Elariny, R. Collantes, and et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients Obes Surg 15 3 2005 310 315
25. N. Vilarrasa, J. Vendrell, R. Sánchez-Santos, and et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients Clin Endocrinol (Oxf) 67 5 2007 679 686
26. J. Vendrell, M. Broch, N. Vilarrasa, and et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity Obes Res 12 6 2004 962 971
27. H.P. Kopp, C.W. Kopp, A. Festa, and et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients Arterioscler Thromb Vasc Biol 23 6 2003 1042 1047
28. D. Papamargaritis, C.W. le Roux, E. Sioka, G. Koukoulis, G. Tzovaras, and D. Zacharoulis Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy Surg Obes Relat Dis 9 2 2013 192 201
29. G.M. Campos, C. Rabl, P.J. Havel, and et al. Changes in post-prandial glucose and pancreatic hormones, and steady-state insulin and free fatty acids after gastric bypass surgery Surg Obes Relat Dis 10 1 2014 1 8
30. J.P. O'Leary Hepatic complications of jejunoileal bypass Semin Liver Dis 3 3 1983 203 215
31. J.D. Maxwell, I. Sanderson, W.H. Butler, J.C. Gazet, and T.R. Pilkington Hepatic structure and function after modified jejunoileal bypass surgery for obesity Br Med J 2 6089 1977 726 729
32. F.H. Luyckx, C. Desaive, A. Thiry, and et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty Int J Obes Relat Metab Disord 22 3 1998 222 226
33. C. Stratopoulos, A. Papakonstantinou, I. Terzis, and et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity Obes Surg 15 8 2005 1154 1160
34. P. Mathurin, A. Hollebecque, L. Arnalsteen, and et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease Gastroenterology 137 2 2009 532 540
35. J.G. Kral, S.N. Thung, S. Biron, and et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis Surgery 135 1 2004 48 58
36. K.B. Barker, N.A. Palekar, S.P. Bowers, J.E. Goldberg, J.P. Pulcini, and S.A. Harrison Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery Am J Gastroenterol 101 2 2006 368 373
37. E.M. Silverman, J.A. Sapala, and H.D. Appelman Regression of hepatic steatosis in morbidly obese persons after gastric bypass Am J Clin Pathol 104 1 1995 23 31
38. A. Csendes, G. Smok, and A.M. Burgos Histological findings in the liver before and after gastric bypass Obes Surg 16 5 2006 607 611
39. X. Liu, A.J. Lazenby, R.H. Clements, N. Jhala, and G.A. Abrams Resolution of nonalcoholic steatohepatits after gastric bypass surgery Obes Surg 17 4 2007 486 492
40. M. Moretto, C. Kupski, V.D. da Silva, A.V. Padoin, and C.C. Mottin Effect of bariatric surgery on liver fibrosis Obes Surg 22 7 2012 1044 1049
41. A. Keshishian, K. Zahriya, and E.B. Willes Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months Obes Surg 15 10 2005 1418 1423
42. E.M. Brunt, D.E. Kleiner, L.A. Wilson, and et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD -Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network Hepatology 49 3 2009 809 820
43. S. Klein, B. Mittendorfer, J.C. Eagon, and et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 6 2006 May 1 1564 1572
44. R. Caiazzo, G. Lassailly, E. Leteurtre, and et al. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study Ann Surg 260 5 2014 893 899
45. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 9 1999 2467 2474
46. Y. Sumida, A. Nakajima, and Y. Itoh Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis World J Gastroenterol 20 2 2014 475 485